￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Brigatinib treats patients with ALK+ non-small cell lung cancer, and the progression-free survival benefit is more obvious!

2025-10-19 11:44:20

Check Details
Data on the effectiveness of the MET inhibitor capmatinib in the treatment of lung cancer_ Kanghule

2025-10-19 11:44:20

Check Details
Capmatinib has a significant effect in the treatment of MET mutated lung cancer

2025-10-19 11:44:20

Check Details
Dosage and administration method of anticancer drug crizotinib

2025-10-19 11:44:20

Check Details
Gefitinib is a new targeted drug for the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The emergence of crizotinib brings survival benefits to patients with non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The effect of gefitinib treatment on patients with advanced lung cancer

2025-10-19 11:44:20

Check Details
Can lung cancer brain metastases be treated with gefitinib?

2025-10-19 11:44:20

Check Details
Safety and effectiveness of gefitinib targeted treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Tepotinib is a potent and highly selective oral MET inhibitor_ Kanghule

2025-10-19 11:44:20

Check Details
How much does a box of the new lung cancer drug Bozitinib cost? Where can I buy it?

2025-10-19 11:44:20

Check Details
What should we pay attention to when using tepotinib to treat lung cancer?

2025-10-19 11:44:20

Check Details
Category
相关知识